
Ovral
Ovral is the original brand of ethinylestradiol with norgestrel, a combined oral contraceptive, and a generic equivalent is supplied as 0.15/0.03mg and 0.5/0.05mg tablets for contraception.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 0.15/0.03mg | 21 tablets | $12.60 | $0.60 |
| 0.15/0.03mg | 42 tablets | $17.64 | $0.42 |
| 0.15/0.03mg | 63 tablets | $23.31 | $0.37 |
| 0.15/0.03mg | 105 tablets | $35.70 | $0.34 |
| 0.5/0.05mg | 20 tablets | $23.80 | $1.19 |
| 0.5/0.05mg | 40 tablets | $46.00 | $1.15 |
| 0.5/0.05mg | 60 tablets | $66.00 | $1.10 |
| 0.5/0.05mg | 100 tablets | $106.00 | $1.06 |
- Category
- Women's Health
- Active ingredients
- Ethinylestradiol · Norgestrel
- Route
- Oral use
- Form
- Tablet
- Strengths
- 0.15/0.03 · 0.5/0.05mg
You will receive a quality generic equivalent, depending on stock.
- Condition
- Contraception
- Alternative names
- Eugynon; Microgynon
- Therapeutic class
- Combined Oral Contraceptive
- Pharmacological class
- Oestrogen and Progestogen
- Minor side effects
- nausea; abdominal pain; headache; weight changes
- Moderate side effects
- breast tenderness; mood changes; libido changes; chloasma
- Dosage forms
- Tablet
- Administration route
- Oral use
- Originator
- Pfizer
- Onset time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C, in original packaging.
- Drug interactions
- St. John's Wort; Carbamazepine; Phenytoin; Rifampicin
- Age restrictions
- For use in adult women of reproductive age.
Contraindications
history of venous thromboembolism; history of arterial thromboembolism; severe hypertension; breast cancer; known or suspected pregnancy
Precautions and warnings
risk of venous thromboembolism may increase with age; stop treatment if signs of thrombosis occur; regular blood pressure monitoring recommended
Serious side effects
venous thromboembolism, requires immediate medical attention; hypertension, requires immediate medical attention; cervical cancer, requires immediate medical attention
Mechanism of action
This product combines an oestrogen and a progestogen to inhibit ovulation, alter cervical mucus consistency to prevent sperm penetration, and modify the endometrium to reduce the likelihood of implantation.
Pregnancy and breastfeeding
Pregnancy: Contraindicated; discontinue if pregnancy occurs. Breastfeeding: Not recommended, may reduce milk production.
Ethinylestradiol and norgestrel form Ovral, a combined oral contraceptive tablet listed in 0.15/0.03mg and 0.5/0.05mg strengths. The oestrogen and progestogen inhibit ovulation, alter cervical mucus to prevent sperm penetration and modify the endometrium to reduce the chance of implantation. Ovral is the original brand, and a generic equivalent is supplied for contraception. It is also sold as Eugynon and Microgynon.
Buying Ovral in Thailand
What you receive is a generic with the same active ingredients, delivered to an address in Thailand or elsewhere in Asia. You can order without a prescription. Delivery to Thailand takes up to 3 weeks by Standard Airmail or up to 1 week by Express Tracked Courier, in plain packaging.
What you will receive
Ovral is the originator brand name, made by Pfizer. We use it here to identify the medicine only; we are not affiliated with Pfizer and do not ship the original Ovral.
- You receive a generic equivalent: the same active ingredient (Ethinylestradiol / Norgestrel) at the same dose, mostly recognised branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- Inactive ingredients, tablet appearance and packaging can differ from the original brand; the active ingredient and dose are the same.